American Journal of Kidney Diseases
Volume 54, Issue 5 , Pages 954-964 , November 2009

Dialysis Delivery in Canada and the United States: A View From the Trenches

  • David C. Mendelssohn, MD, FRCPC

      Affiliations

    • Humber River Regional Hospital and University of Toronto, Toronto, Canada
    • Corresponding Author InformationAddress correspondence to David C. Mendelssohn, MD, FRCPC, Humber River Regional Hospital, 200 Church St, Rm 2024, Weston, Ontario, M9N 1N8 Canada
    • ,
  • Jay B. Wish, MD

      Affiliations

    • Case Western Reserve University, Cleveland, OH

References 

  1. Supreme Court of Canada: Chaoulli v Quebec (Attorney General). http://csc.lexum.umontreal.ca/en/2005/2005scc35/2005scc35.pdfAccessed April 27, 2009
  2. DeNavas-Walt C, Proctor BD, Smith JC US Census Bureau 2005. Income, poverty and health insurance coverage in the United States. http://www.census.gov/prod/2005pubs/p60-229.pdfAccessed April 27, 2009
  3. Hirth RA. The organization and financing of kidney dialysis and transplant care in the United States of America. Int J Health Care Finance Econ. 2007;7:301–318
  4. Manns BJ, Mendelssohn DC, Taub KJ. The economics of end-stage renal disease care in Canada: Incentives and impact on delivery of care. Int J Health Care Finance Econ. 2007;7:146–169
  5. MedPAC: Outpatient dialysis reimbursement system. http://www.medpac.gov/documents/Medpac_Payment_Basics_08_dialysis.pdfAccessed April 27, 2009
  6. MedPAC: Report to Congress: Medicare payment policy. http://www.medpac.gov/documents/Mar05_EntireReport.pdfAccessed April 27, 2009
  7. Ontario Joint Policy and Planning Committee: Review of the micro-costing methodology and recommended rates for chronic kidney disease programs in hospitals. http://www.jppc.org/new/files/acrobat/CKD%20REPORT%20May%2008.pdfAccessed April 27, 2009
  8. US Renal Data System. USRDS 2007 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007;
  9. Canadian Institute for Health Informatics. Treatment of End Stage Organ Failure in Canada 1995-2004 (2006 annual report). Ottawa, Canada: CIHI; 2006;
  10. Mendelssohn DC, Ethier J, Elder SJ, et al. Haemodialysis vascular access problems in Canada: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant. 2006;21:721–728
  11. Mendelssohn DC, Kua BT, Singer PA. Referral for dialysis in Ontario. Arch Intern Med. 1995;155:2473–2478
  12. Mendelssohn DC, Chery A. Dialysis utilization in the Toronto region from 1981 to 1992 (Toronto Region Dialysis Committee). CMAJ. 1994;150:1099–1105
  13. Toronto District Health Council. The Rising Tide of End Stage Renal Disease in Toronto. Toronto, Canada: Toronto District Health Council; 2003;
  14. Kjellstrand C, Moody H. Hemodialysis in Canada: A first class medical crisis. CMAJ. 1994;150:1067–1071
  15. Ontario Joint Policy and Planning Committee: An Approach to Funding End Stage Renal Disease, 1997. http://www.jppc.org/new/files/HTML/EndStageRenalRd5_3.htmAccessed April 27, 2009
  16. Held PJ, Brunner F, Odaka M, et al. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis. 1990;15:451–457
  17. National Kidney Foundation. DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure. Am J Kidney Dis. 1997;30(suppl 3):S192–S240
  18. National Kidney Foundation. DOQI Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis. 1997;30(suppl 3):S150–S191
  19. National Kidney Foundation. DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. Am J Kidney Dis. 1997;30(suppl 2):S67–S136
  20. National Kidney Foundation. DOQI Clinical Practice Guidelines for Hemodialysis Adequacy. Am J Kidney Dis. 1997;30(suppl 2):S15–S66
  21. Centers for Medicare & Medicaid Services. 2006 Annual Report: End Stage Renal Disease Clinical Performance Measures Project. Baltimore, MD: Department of Health and Human Services, Centers for Medicare & Medicaid Services, Office of Clinical Standards & Quality; 2007;
  22. Young EW, Goodkin DA, Mapes DL, et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study. Kidney Int Suppl. 2000;74:S74–S81
  23. Mendelssohn DC, Yeates KE, Ethier J, et al. DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in Canada. Nephrol News Issues. 2007;21:69–7072, 74-76 passim
  24. Port FK, Pisoni RL, Bragg-Gresham JL, et al. DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States. Blood Purif. 2004;22:175–180
  25. Young EW, Akiba T, Albert JM, et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44(suppl 2):S34–S38
  26. Pisoni RL, Bragg-Gresham JL, Young EW, et al. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44:94–111
  27. Ethier J, Mendelssohn DC, Elder SJ, et al. Vascular access use and outcomes: An international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2008;23:3219–3226
  28. Saran R, Bragg-Gresham JL, Levin NW, et al. Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney Int. 2006;69:1222–1228
  29. Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2008;52:519–530
  30. US Renal Data System. USRDS 2008 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008;
  31. Desai AA, Bolus R, Nissenson A, et al. Is there “cherry picking” in the ESRD Program? (Perceptions from a dialysis provider survey). Clin J Am Soc Nephrol. 2009;4:772–777
  32. The Renal Network: Barriers to Outpatient Dialysis Placement. Final Project Report. http://www.therenalnetwork.org/services/resources/pdf/barriersfinalreport6.05.pdfAccessed April 27, 2009
  33. Ethier J, Mendelssohn DC, Elder SJ, et al. Vascular access use and outcomes: An international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2008;23:3219–3226
  34. Blake PG, Finkelstein FO. Why is the proportion of patients doing peritoneal dialysis declining in North America?. Perit Dial Int. 2001;21:107–114
  35. Heaf J. Underutilization of peritoneal dialysis. JAMA. 2004;291:740–742
  36. Mehrotra R, Blake P, Berman N, Nolph KD. An analysis of dialysis training in the United States and Canada. Am J Kidney Dis. 2002;40:152–160
  37. Mehrotra R. Peritoneal dialysis penetration in the United States: March toward the fringes?. Perit Dial Int. 2006;26:419–422
  38. Jager KJ, Korevaar JC, Dekker FW, et al. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis. 2004;43:891–899
  39. Oliver MJ, Quinn RR, Richardson EP, et al. Home care assistance and the utilization of peritoneal dialysis. Kidney Int. 2007;71:673–678
  40. Jung B, Blake PG, Mehta RL, Mendelssohn DC. Attitudes of Canadian nephrologists toward dialysis modality selection. Perit Dial Int. 1999;19:263–268
  41. Mendelssohn DC, Mullaney SR, Jung B, et al. What do American nephrologists think about dialysis modality selection?. Am J Kidney Dis. 2001;37:22–29
  42. Mendelssohn DC. Reflections on the optimal dialysis modality distribution: A North American perspective. Nephrol News Issues. 2002;16:26–30
  43. Mendelssohn DC. Empowerment of patient preference in dialysis modality selection. Am J Kidney Dis. 2004;43:930–932
  44. US Renal Data System. The USRDS Dialysis Morbidity and Mortality Study: Wave 2 (Chapter IV), in Excerpts From the United States Renal Data System 1997 Annual Data Report. Am J Kidney Dis. 1997;30(suppl 1):S67–S85
  45. Lameire N, Van Biesen W, Dombros N, et al. The referral pattern of patients with ESRD is a determinant in the choice of dialysis modality. Perit Dial Int. 1997;17(suppl 2):S161–S166
  46. Prichard SS. Treatment modality selection in 150 consecutive patients starting ESRD therapy. Perit Dial Int. 1996;16:69–72
  47. Oliver MJ, Quinn RR, Richardson EP, et al. Home care assistance and the utilization of peritoneal dialysis. Kidney Int. 2007;71:673–678
  48. Berns JS, O'Neill WC. Performance of procedures by nephrologists and nephrology fellows at U.S. nephrology training programs. Clin J Am Soc Nephrol. 2008;3:941–947
  49. Mendelssohn DC, Langlois N, Blake PG. Peritoneal dialysis in Ontario: A natural experiment in physician reimbursement methodology. Perit Dial Int. 2004;24:531–537
  50. Oreopoulos DG, Coleman S, Doyle E. Reversing the decreasing peritoneal dialysis (PD) trend in Ontario: A government initiative to increase PD use in Ontario to 30% by 2010. Perit Dial Int. 2007;27:489–495
  51. Lindsay RM, Heidenheim AP, Leitch R, et al. Short daily versus long nocturnal hemodialysis (Daily/Nocturnal Dialysis Study Group). ASAIO J. 2001;47:449–455
  52. Pierratos A. Daily nocturnal home hemodialysis. Kidney Int. 2004;65:1975–1986
  53. Mendelssohn DC, for the CSNP. Public Policy C (Principles of end stage renal disease care). Ann R Coll Physicians Surg Canada. 1997;30:271–273
  54. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function—Measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–2483
  55. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 2):S1–S266
  56. Mendelssohn DC, Toffelmire EB, Levin A. Attitudes of Canadian nephrologists toward multidisciplinary team-based CKD clinic care. Am J Kidney Dis. 2006;47:277–284
  57. Levin A, Mendelssohn DC Care and Referral of Adult Patients with Reduced Kidney Function: Position Paper From the Canadian Society of Nephrology, 2006. http://www.csnscn.ca/local/files/CSN-Documents/CSN%20Postion%20Paper%20Sept2006.pdfAccessed April 27, 2009
  58. Phillips N, Barrett B, Mendelssohn DC. The role of physicians in political advocacy (Results of a Canadian Society of Nephrology survey). Nephrol News Issues. 2008;22:32–3336-37
  59. Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085–2098
  60. Drueke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355:2071–2084
  61. Thamer M, Zhang Y, Kaufman J, et al. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis. JAMA. 2007;297:1667–1674
  62. National Kidney Foundation. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target. Am J Kidney Dis. 2007;50:471–530
  63. Pisoni RL, Arrington CJ, Albert JM, et al. Facility hemodialysis vascular access use and mortality in countries participating in the DOPPS: An instrumental variable analysis. Am J Kidney Dis. 2009;53:475–491
  64. Dor A, Pauly MV, Eichleay MA, Held PJ. End-stage renal disease and economic incentives: The International Study of Health Care Organization and Financing (ISHCOF). Int J Health Care Finance Econ. 2007;7:73–111

 Originally published online as doi: 10.1053/j.ajkd.2009.05.023 on September 3, 2009.

PII: S0272-6386(09)00936-6

doi: 10.1053/j.ajkd.2009.05.023

American Journal of Kidney Diseases
Volume 54, Issue 5 , Pages 954-964 , November 2009

Article Tools

* Image Usage & Resolution